Alterations in multiple pathways, including the insulin response, β-oxidation, lipid storage and transport, and autophagy pathways, are closely interrelated and are indistinguishable with regard to their contributions to NAFLD and HCC13,14. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.